Briefing19 July 2026·7 min read
The Peptide Pipeline Moved From Promising to Pivotal. The More Challenging Question Is What Happens Next.
Two Phase 3 readouts have reset the ceiling for what peptide therapeutics can do. The more interesting story is everything the efficacy headline leaves out.